Products - Arthritis | Topic | NICE

Showing 5 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Bimekizumab for treating ankylosing spondylitis [ID4011]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Digital technologies for managing mild to moderate symptoms of hip or knee osteoarthritis: early value assessment (HTG766)
Product type:
Guidance
Programme:
HealthTech guidance
Published:
22 January 2026
Filgotinib for treating axial spondyloarthritis [ID6594]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Hip resurfacing for hip arthritis
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal) (TA1104)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
22 October 2025